Table 1.
Control subjects | Breast cancer Patients | Control subjects | Breast cancer Patients | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||
Authors | Publication year | Country | Case/control | LL | LM | MM | LL | LM | MM | QR | RR | QR | RR | HWE | ||
Stevens et al. | 2006 | USA | 483/483 | 202 | 223 | 58 | 176 | 230 | 77 | 238 | 198 | 47 | 259 | 182 | 42 | |
Antognelli et al. | 2009 | Italy | 547/544 | 188 | 125 | 231 | 107 | 115 | 325 | 340 | 152 | 52 | 484 | 50 | 13 | |
Naidu et al. | 2010 | Malaysia | 387/252 | 126 | 109 | 17 | 159 | 178 | 50 | 115 | 115 | 22 | 200 | 158 | 29 | |
Hussein et al. | 2011 | Egypt | 200/200 | 81 | 65 | 54 | 70 | 62 | 68 | 46 | 42 | 12 | 51 | 41 | 8 | |
Agachan et al. | 2006 | Turkey | 33/52 | - | - | - | - | - | - | 17 | 29 | 6 | 17 | 4 | 12 | |
Gallicchio et al. | 2007 | USA | 58/904 | - | - | - | - | - | - | 469 | 353 | 82 | 38 | 15 | 5 | |
DeRoo et al. | 2014 | USA | 294/646 | HR=0.96 (95% CI: 0.78-1.20) | HR=0.97 (95% CI: 0.77-1.22) |